Pharmacological Targeting of the Actin Cytoskeleton to Drive Endocrinogenesis
- PMID: 32340752
- DOI: 10.1016/j.tips.2020.04.002
Pharmacological Targeting of the Actin Cytoskeleton to Drive Endocrinogenesis
Abstract
In vitro generation of insulin-secreting beta cells from human pluripotent stem cells (hPSCs) opens new avenues for treating and modeling diabetes. Hogrebe and colleaguesestablished a new 2D differentiation protocol where they targeted the cytoskeleton pharmacologically for controlled endocrine induction and generation of hPSC-derived beta cells with improved function.
Keywords: Latrunculin A; actin; beta cells; endocrine progenitors; pancreatic progenitors; stem cells.
Copyright © 2020 Elsevier Ltd. All rights reserved.
Comment on
-
Targeting the cytoskeleton to direct pancreatic differentiation of human pluripotent stem cells.Nat Biotechnol. 2020 Apr;38(4):460-470. doi: 10.1038/s41587-020-0430-6. Epub 2020 Feb 24. Nat Biotechnol. 2020. PMID: 32094658 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources